Sabai Global Clinical Biosafety Services Castle IRB Shield Consulting
Click the Logo to show Blogs related to that category.
CONTENT TYPE
Whitepapers
Infographics
Social Media
Events
Company News
Content Coming Soon
Card image cap
Gene Therapy in Action: Volume #4

In "HGT in Action #4", Caitlyn Hauke, PhD, RBP, CBSP(ABSA) discusses the rare genetic blood disorder, Thalassemia. Inside, we highlight gene therapy as a treatment, three current clinical trials, and one FDA-approved gene therapy product.

Learn More Here
Card image cap
Thompson Street Capital Partners Invests in Sabai Global

Sabai Global is excited to announce its new partnership with TSCP. Our partnership will propel Sabai Global to new heights of innovation and growth, and we eagerly anticipate our continued and shared successes.

Read more in our press release below, published by Business Wire.

Learn More Here
Card image cap
CEO Chris Featured in Parexel xTalk

Watch the official webinar, 'Moving Cell and Gene Therapy Trials into the Community: Challenges and Opportunities', below.

Learn More Here
Card image cap
Congratulations to Heidi Page, Shield Consulting's New Director!

A very big congratulations to Heidi Page, MS, RBP for her promotion to Director of Shield Consulting! Thank you for your continued commitment and hard work, we look forward to our continued successes!

Learn More Here
Card image cap
We're Attending AAHRPP 2023!

The Castle IRB team is eager to attend this year's annual AAHRPP conference! Read more about the event below.

Learn More Here
Card image cap
Congratulations, Melissa Fitzgerald!

Congratulations to Melissa Fitzgerald on her promotion to Operations Manager! We are proud to acknowledge her passion, expertise, and unwavering commitment to our team.

Learn More Here
Card image cap
Congratulations on Your Promotion, Jessica Poole!

Congratulations, Jessica Poole, on your promotion to Operations Manager! We greatly appreciate your exceptional expertise and are proud to recognize the invaluable contributions you bring to our operations.

Learn More Here
Card image cap
Sabai Global Celebrates Rare Disease Day 2023

The Sabai family is proud to celebrate this year's Rare Disease day, February 28th. Click below for more information:

Learn More
Card image cap
Overview: Updated NIH Date Management Sharing Policy

Join us in breaking down this up to date NIH policy, effective January 25th.

Learn More
Card image cap
Gene Therapy in Action: Volume #3

Join us this month in discussing Hunter’s Syndrome (MPS II), an impactful rare disease affecting the metabolism of carbohydrates in the body.

Learn More
Card image cap
Gene Therapy Seminar Series February 2023

This month, we discussed recent advancements in human gene therapy technologies and their application in addressing sensorineural hearing loss.

Learn More
Card image cap
Welcome to the Team, Dr. Reeme!

A very warm welcome to Allison Reeme, who has joined our Shield Consulting team as a Project Manager – Biosafety Officer!

Learn More
Card image cap
Gene Therapy in Action: Volume #2

This month we are exploring Fabry Disease, a rare genetic disease that affects the metabolism of glycosphingolipids.

Learn More
Card image cap
Gene Therapy in Action: Volume #1

Introducing Gene Therapy in Action, our latest blog-style publication spotlighting rare diseases and cancers. This week we are exploring Amyotrophic Lateral Sclerosis (ALS)

Learn More

Mission Statement

SABAI Global's Mission is to be considered a "World Renowned Thought Leader" in the IBC and IRB space, facilitating positive change in medicine and in the lives of many people; and maintaining the status of an "Employer of Choice" by demonstrating daily, the value we place on our employees, consultants and partners.